Xeris Pharmaceuticals Inc reported $124.37M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 51.75M 7.22M
Acura Pharmaceuticals ACUR:US 1.31M 70K
Eli Lilly And LLY:US $ 17808.3M 512.8M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
Horizon Pharma HZNP:US $ 2413.92M 238.54M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Perrigo Ordinary Shares PRGO:US $ 4225.9M 194.3M
Supernus Pharmaceuticals SUPN:US $ 668.38M 29.13M
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M
Zogenix ZGNX:US $ 375.46M 40.93M